Education
About Us
Working with TipRanks
Follow Us
Claritas Pharmaceuticals (CLAZF)
OTHER OTC:CLAZF
CLAZF Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume4.20K
Average Volume (3M)N/A
Market Cap
$828.84K
Enterprise ValueN/A
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta54.41
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding37,786,587
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CLAZF FAQ
What was Claritas Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is Claritas Pharmaceuticals’s market cap?
Claritas Pharmaceuticals’s market cap is $828.84K.
When is Claritas Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Claritas Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Claritas Pharmaceuticals overvalued?
According to Wall Street analysts Claritas Pharmaceuticals’s price is currently Overvalued.
Does Claritas Pharmaceuticals pay dividends?
Claritas Pharmaceuticals does not currently pay dividends.
What is Claritas Pharmaceuticals’s EPS estimate?
Claritas Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Claritas Pharmaceuticals have?
Claritas Pharmaceuticals has 37,786,587 shares outstanding.
What happened to Claritas Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Claritas Pharmaceuticals?
Currently, no hedge funds are holding shares in CLAZF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Claritas Pharmaceuticals
Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.
Technical Analysis
Artelo Biosciences
―
China Pharma Holdings
―
CytoDyn
―
Enzolytics
―
EyePoint Pharmaceuticals
―
Xencor
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---